Canadian Sec - Delayed Quote CAD

Cresco Labs Inc. (CL.CN)

Compare
1.6900 +0.0200 (+1.20%)
At close: 3:58 PM EST
Loading Chart for CL.CN
DELL
  • Previous Close 1.6700
  • Open 1.5800
  • Bid 1.6500 x --
  • Ask 1.7000 x --
  • Day's Range 1.5800 - 1.8300
  • 52 Week Range 1.4100 - 3.5800
  • Volume 193,849
  • Avg. Volume 191,527
  • Market Cap (intraday) 587.63M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.2500
  • Earnings Date Nov 8, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 2.70

Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections and fruit-forward gummies under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company was incorporated in 1990 and is headquartered in Chicago, Illinois.

www.crescolabs.com

2,760

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CL.CN

View More

Performance Overview: CL.CN

Trailing total returns as of 11/26/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CL.CN
5.59%
S&P/TSX Composite index
21.22%

1-Year Return

CL.CN
24.22%
S&P/TSX Composite index
26.37%

3-Year Return

CL.CN
84.84%
S&P/TSX Composite index
17.54%

5-Year Return

CL.CN
77.82%
S&P/TSX Composite index
49.15%

Compare To: CL.CN

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CL.CN

View More

Valuation Measures

Annual
As of 11/25/2024
  • Market Cap

    580.68M

  • Enterprise Value

    1.33B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.56

  • Price/Book (mrq)

    0.91

  • Enterprise Value/Revenue

    1.29

  • Enterprise Value/EBITDA

    7.27

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -9.19%

  • Return on Assets (ttm)

    5.22%

  • Return on Equity (ttm)

    -14.17%

  • Revenue (ttm)

    733.45M

  • Net Income Avi to Common (ttm)

    -67.43M

  • Diluted EPS (ttm)

    -0.2500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    153.3M

  • Total Debt/Equity (mrq)

    188.97%

  • Levered Free Cash Flow (ttm)

    57.8M

Research Analysis: CL.CN

View More

Company Insights: CL.CN

Research Reports: CL.CN

View More

People Also Watch